Acquired primary cutaneous ganglioneuroma with adipocytic metaplasia: "An end point of melanocytic 'maturation'?" A case report and meta-analysis with comparison to a cross-sectional study of neurotized melanocytic nevi

American Journal of Dermatopathology

Volumn 33, Issue 1, 2011, Pages 17-26

  Li, Li ^a   Slominski, Andrzej ^b   Qian, Jiang ^a   Carlson, J Andrew ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Abtropfung; cutaneous ganglioneuroma; hochsteigerung; maturation; melanocytic nevus; neoplastic multidirectional differentiation; neural crest; neurotization; stem cells; transformation

Indexed keywords

CALCYCLIN; CD56 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; NEURON SPECIFIC ENOLASE; PROTEIN S 100; STEM CELL FACTOR RECEPTOR; SYNAPTOPHYSIN;

ADIPOCYTE; ADIPOCYTE METAPLASIA; AGED; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CROSS-SECTIONAL STUDY; CYTOPLASM; DISEASE DURATION; FEMALE; GANGLIONEUROMA; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFLAMMATION; MALE; MELANOCYTE; MELANOCYTIC NEVUS; METAPLASIA; NERVE CELL; NERVE FIBER; NERVE SHEATH; NEURAL CREST CELL; NEURAL STEM CELL; NEUROFILAMENT; NEUROTIZED MELANOCYTIC NEVI; PAPILLOMATOSIS; PAPULE; PHENOTYPE; PRIMARY CUTANEOUS GANGLIONEUROMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL; SEBORRHEIC KERATOSIS; SPINDLE CELL; TUMOR BIOPSY; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VOLUME;

ADIPOCYTES; AGED; FEMALE; GANGLIONEUROMA; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOCYTES; METAPLASIA; NEVUS, PIGMENTED; SKIN NEOPLASMS;

EID: 78951479530     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181e448cb     Document Type: Article

References (75)

1. Montgomery H, O'Leary PA. Multiple ganglioneuromas of the skin: report of a case with the differential diagnosis from reticulohistocytic granuloma, neuroma, xanthoma and von Recklinghausens disease. Arch Derm Syph. 1934;29:26-52.
2. Bolande RP, Towler WF. A possible relationship of neuroblastoma to Von Recklinghausens disease. Cancer. 1970;26:162-175.
3. Gambini C, Rongioletti F. Primary congenital cutaneous ganglioneuroma. J Am Acad Dermatol. 1996;35(2 pt 2):353-354.
4. Collins JP, Johnson WC, Burgoon CF Jr. Ganglioneuroma of the skin. Arch Dermatol. 1972;105:256-258.
5. Al-Daraji WI, Al-Dawoud A. Primary cutaneous ganglioneuroma arising within a seborrheic keratosis: a rare association. Clin Exp Dermatol. 2005; 30:137-140.
6. Franchi A, Massi D, Santucci M. Desmoplastic cutaneous ganglioneuroma. Histopathology. 1999;34:82-84.
7. Furmanczyk PS, Hughes SR, Walsh JS, et al. Cutaneous ganglioneuroma associated with overlying hyperkeratotic epidermal changes: a report of 2 cases. Am J Dermatopathol. 2008;30:600-603.
8. Geffner RE, Hassell CM. Ganglioneuroma of the skin. Arch Dermatol. 1986;122:377-378.
9. Hammond RR,Walton JC. Cutaneous ganglioneuromas: a case report and review of the literature. Hum Pathol. 1996;27:735-738.
10. Lee JY, Martinez AJ, Abell E. Ganglioneuromatous tumor of the skin: a combined heterotopia of ganglion cells and hamartomatous neuroma: report of a case. J Cutan Pathol. 1988;15:58-61.
11. Lloyd RV, James N, Breach NM, et al. Development of ganglioneuroma following successful treatment for orbital rhabdomyosarcoma. Br J Plast Surg. 1998;51:135-137.
12. Murphy M, Hoss D, Berke A, et al. Cutaneous ganglioneuroma. Int J Dermatol. 2007;46:861-863.
13. Ohno S, Horiguchi Y, Shintaku M. A case of cutaneous ganglioneuroma developing within a lesion of seborrheic keratosis. J Dermatol. 2002;29: 300-304.
14. Radice F, Gianotti R. Cutaneous ganglion cell tumor of the skin. Case report and review of the literature. Am J Dermatopathol. 1993;15: 488-491.
15. Rios JJ, Diaz-Cano SJ, Rivera-Hueto F, et al. Cutaneous ganglion cell choristoma. Report of a case. J Cutan Pathol. 1991;18:469-473.
16. Saikali S, Paumier V, Garrelon JL, et al. [Facial primary cutaneous ganglioneuroma]. Ann Pathol. 2009;29:138-141.
17. Wallace CA, Hallman JR, Sangueza OP. Primary cutaneous ganglioneuroma: a report of two cases and literature review. Am J Dermatopathol. 2003;25:239-242.
18. Reed RJ. Neuromesenchyme. The concept of a neurocristic effector cell for dermal mesenchyme. Am J Dermatopathol. 1983;5:385-395.
19. Massi G, LeBoit PE. Common nevus. In: Massi G, LeBoit PE, eds. Histological Diagnosis of Nevi and Melanoma. Darmstadt, Germany: DE Steinkopf Verlag Deamstadt; 2004:35-70.
20. Misago N. The relationship between melanocytes and peripheral nerve sheath cells (part I): melanocytic nevus (excluding so-called blue nevus) with peripheral nerve sheath differentiation. Am J Dermatopathol. 2000;22: 217-229.
21. Le Douarin NM, Calloni GW, Dupin E. The stem cells of the neural crest. Cell Cycle. 2008;7:1013-1019.
22. Nagoshi N, Shibata S, Nakamura M, et al. Neural crest-derived stem cells display a wide variety of characteristics. J Cell Biochem. 2009;107: 1046-1052.
23. Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol. 1996;20:277-285.
24. Tran TA, Muller S, Chaudahri PJ, et al. Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis. J Cutan Pathol. 2005;32:2-11.
25. DeLellis RA, Tischler AS, Wolfe HJ. Multidirectional differentiation in neuroendocrine neoplasms. J Histochem Cytochem. 1984;32:899-904.
26. Gould VE, Memoli VA, Dardi LE, et al. Neuroendocrine carcinomas with multiple immunoreactive peptides and melanin production. Ultrastruct Pathol. 1981;2:199-217.
27. Nowell PC. Mechanisms of tumor progression. Cancer Res. 1986;46: 2203-2207.
28. Sell S. Cancer stem cells and differentiation therapy. Tumour Biol. 2006; 27:59-70.
29. Jurecka W. Pigmented neurofibroma. J Dermatol. 1988;15:172-179.
30. Karcioglu Z, Someren A, Mathes SJ. Ectomesenchymoma. A malignant tumor of migratory neural crest (ectomesenchyme) remnants showing ganglionic, schwannian, melanocytic and rhabdomyoblastic differentiation. Cancer. 1977;39:2486-2496.
31. Normanskii VE, Bershchanskaia AM. [Melanoma with a rhabdopoietic differentiation (ectomesenchymoma)]. Arkh Patol. 1986;48:73-76.
32. Carlson JA, Dickersin GR. Melanotic paraganglioid carcinoid tumor: a case report and review of the literature. Ultrastruct Pathol. 1993;17: 353-372.
33. Goncharuk V, Mulvaney M, Carlson JA. Bednar tumor associated with dermal melanocytosis: melanocytic colonization or neuroectodermal multidirectional differentiation? J Cutan Pathol. 2003;30:147-151.
34. Nakamura T, Ogata H, Katsuyama T. Pigmented dermatofibrosarcoma protuberans. Report of two cases as a variant of dermatofibrosarcoma protuberans with partial neural differentiation. Am J Dermatopathol. 1987;9:18-25.
35. Alguacil-Garcia A, Unni K, Goellner J. Histogenesis of Dermatofibrosarcoma protruberans: An ultrastructural study. Am J Clin Pathol. 1978; 69:427-434.
36. Hashimoto K, Brownstein MH, Jakobiec FA. Dermatofibrosarcoma protuberans. A tumor with perineural and endoneural cell features. Arch Dermatol. 1974;110:874-885.
37. Misago N, Narisawa Y, Inoue T, et al. Unusually differentiating immature nerve sheath myxoma in association with dermal melanocytosis. Am J Dermatopathol. 1999;21:55-62.
38. Smith KJ, Mezebish D, Williams J, et al. The spectrum of neurocristic cutaneous hamartoma: clinicopathologic and immunohistochemical study of three cases. Ann Diagn Pathol. 1998;2:213-223.
39. Misago N. The relationship between melanocytes and peripheral nerve sheath cells (Part II): blue nevus with peripheral nerve sheath differentiation. Am J Dermatopathol. 2000;22:230-236.
40. Carlson JA, Dickersin GR, Sober AJ, et al. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer. 1995;75: 478-494.
41. Massi G, LeBoit PE. Melanoma with neural differentiation. In: Massi G, LeBoit PE, eds.Histological Diagnosis of Nevi and Melanoma. Darmstadt, Germany: DE Steinkopf Verlag Deamstadt; 2004:509-514.
42. Banerjee SS, Menasce LP, Eyden BP, et al. Malignant melanoma showing ganglioneuroblastic differentiation: report of a unique case. Am J Surg Pathol. 1999;23:582-588.
43. Kacerovska D, Michal M, Sosna B, et al. Carcinoid-like pattern in melanoma: report of 4 cases. Am J Dermatopathol. 2009;31:542-550.
44. Vierbuchen T, Ostermeier A, Pang ZP, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature. 2010;463: 1035-1041.
45. Gray MH, Smoller BR, McNutt NS, et al. Neurofibromas and neurotized melanocytic nevi are immunohistochemically distinct neoplasms. Am J Dermatopathol. 1990;12:234-241.
46. Gray MH, Smoller BR, McNutt NS, et al. Immunohistochemical demonstration of factor XIIIa expression in neurofibromas. A practical means of differentiating these tumors from neurotized melanocytic nevi and schwannomas. Arch Dermatol. 1990;126:472-476.
47. Witt C, Krengel S. Clinical and epidemiological aspects of subtypes of melanocytic nevi (Flat nevi, Miescher nevi, Unna nevi). Dermatol Online J. 2010;16:1.
48. Fullen DR, Reed JA, Finnerty B, et al. S100A6 preferentially labels type C nevus cells and nevic corpuscles: additional support for schwannian differentiation of intradermal nevi. J Cutan Pathol. 2001;28:393-399.
49. King R, Googe PB, Weilbaecher KN, et al. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol. 2001;25:51-57.
50. Drut R, Drut RM, Cohen M. Adnexal-centered giant congenital melanocyte nevus with extensive ganglioneuromatous component and trisomy 7. Pediatr Dev Pathol. 1999;2:473-477.
51. White RM, Zon LI. Melanocytes in development, regeneration, and cancer. Cell Stem Cell. 2008;3:242-252.
52. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131: 861-872.
53. Aasen T, Raya A, Barrero MJ, et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol. 2008;26:1276-1284.
54. Utikal J, Maherali N, Kulalert W, et al. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci. 2009;122(pt 19):3502-3510.
55. Slominski A. Coming of age of melanogenesis-related proteins. Arch Pathol Lab Med. 2002;126:775-777.
56. Worret WI, Burgdorf WH. Which direction do nevus cells move? Abtropfung reexamined. Am J Dermatopathol. 1998;20:135-139.
57. Winkelmann RK, Rocha G. The dermal nevus and statistics. An evaluation of 1,200 pigmented lesions. Arch Dermatol. 1962;86:310-315.
58. Slominski A, Tobin DJ, Shibahara S, et al. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004;84: 1155-1228.
59. Slominski A, Wortsman J, Plonka PM, et al. Hair follicle pigmentation. J Invest Dermatol. 2005;124:13-21.
60. Meischer G, von Albertini A. Histologie de 100 denaevipigmentaires dapres les methodes de Masson. Bull Soc Fr Dermatol Syph. 1935;42:1265.
61. Cramer SF. The histogenesis of acquired melanocytic nevi. Based on a new concept of melanocytic differentiation. Am J Dermatopathol. 1984; 6(Suppl):289-298.
62. Cramer SF. Stem cells for epidermal melanocytes-a challenge for students of dermatopathology. Am J Dermatopathol. 2009;31:331-341.
63. Unna PG. Naevi and naevocarcinome. Berl Klin Wochenschr. 1893;30:14.
64. Cramer SF. The origin of epidermal melanocytes. Implications for the histogenesis of nevi and melanomas. Arch Pathol Lab Med. 1991;115: 115-119.
65. Krengel S. Nevogenesis-new thoughts regarding a classical problem. Am J Dermatopathol. 2005;27:456-465.
66. Dadzie OE, Goerig R, Bhawan J. Incidental microscopic foci of nevic aggregates in skin. Am J Dermatopathol. 2008;30:45-50.
67. Zalaudek I, Ferrara G, Argenziano G. Dermoscopy insights into nevogenesis: Abtropfung vs Hochsteigerung. Arch Dermatol. 2007;143:284.
68. Busam KJ, Chen YT, Old LJ, et al. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol. 1998;22:976-982.
69. Blokx WA, van Dijk MC, Ruiter DJ. Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects. Histopathology. 2010;56:121-132.
70. Ha L, Merlino G, Sviderskaya EV. Melanomagenesis: overcoming the barrier of melanocyte senescence. Cell Cycle. 2008;7:1944-1948.
71. Sareen D, McMillan E, Ebert AD, et al. Chromosome 7 and 19 trisomy in cultured human neural progenitor cells. PLoS One. 2009;4:e7630.
72. Carless MA, Griffiths LR. Cytogenetics of melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:227-240.
73. Masson P. My conception of cellular nevi. Cancer. 1951;4:9-38.
74. Zalaudek I, Marghoob AA, Scope A, et al. Three roots of melanoma. Arch Dermatol. 2008;144:1375-1379.
75. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocrine Rev. 2000;21:457-487.